Q2 2024 Arcadia Biosciences Inc Earnings Call Transcript

Aug 13, 2024 / 08:30PM GMT
Operator

Good afternoon, and welcome to Arcadia Biosciences second quarter 2024 financial results and business highlights conference call. (Operator Instructions) Please be advised that today’s conference is being recorded. I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead.

Mark Kawakami – Arcadia Biosciences Inc – Chief Financial Officer

Thank you and good afternoon. Joining me on the call today is T J Schaefer, Acadia’s President, and Chief Executive Officer. This call is being webcast and you can refer to the company’s press release at arcadia bio.com. Before we start, we’d like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information.

However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied today. You can review the company’s Safe Harbor language in our most

MORE IN INSIDE INVESTMENT NEWS

Moderna Outlook Surges: Bullish Q3 Beats and Upgraded 2026 Forecast Signal Alpha

Published: Friday, November 6, 2026 · 7:39 AM

Rheinmetall Plunges: Alpha Strategy Amidst Stalled Contracts

Published: Thursday, November 5, 2026 · 3:17 AM